06/06/2026
What happens when appetite is chemically silenced and food becomes repugnant?
For decades, psychotherapists have worked with the emotional meanings of hunger, desire, longing, and need. But the rapid rise of GLP-1 medications such as Ozempic, Wegovy, and Mounjaro is transforming the landscape of bodies, appetite, and eating in ways we are only beginning to understand.
We're delighted to welcome Jean Petrucelli, PhD, internationally recognised expert in eating disorders and editor of the award-winning Body-States, to explore these questions in her thought-provoking presentation:
Bodies in Trouble: A Psychoanalytic Look at the Collision of Bodies, Appetite, and Desire. Are the GLP-1 Medications More Friend or Foe?
Drawing on her pioneering work in embodied experience, dissociation, self-regulation, and the interpersonal treatment of eating disorders, Jean will examine the opportunities and risks these medications present for patients and clinicians alike.
As she reminds us, the challenge remains helping patients learn to live from their bodies rather than manage them.
Compulsive Eating & GLP-1 Weight Loss Drugs: Appetite, Control, Longing and Desire in the Consulting Room.
Join Jean Petrucelli, Susie Orbach, and Tom Wooldridge for an important conversation about the future of psychotherapy in the GLP-1 era.
β οΈ Jean Petrucelli's presentation will not be recorded.
π
Friday, June 12, 2026 | 2:00 pm - 5:30 pm (UK)
π Zoom
π Ticket includes: Certificate (3.5 CPD credits)
π Join the conversation: https://trtogether.com/events/compulsive-eating-weight-loss-drugs